“…This allows for exact checks on the release of cargo using a stimulus, whether internal and pathological characteristics are addressed or whether the physician is external. The regulation provided by the MSNs-responsive mechanism prevents the early release of the therapeutic substance, which could be important in preventing systemic toxicity (Cauda et al 2020;Zhou et al 2018;Vallet-Regí et al 2018). By modifying the physicochemical parameters of the chosen mesoporous materials, the nature of the drug's interactions can be altered.…”
Section: Applicability Of Mesoporous Materials For Sustained or Controlled Drug Delivery Systemsmentioning
Effective treatment of patients suffering from fatal diseases such as cancer, AIDS, tuberculosis, etc., has always been a challenge, and new approaches are continuously explored so as to prevent or reduce the toxic side effects of such drugs. The exploration of silica-based mesoporous nanoparticles as a host for better therapeutic action of drugs has provided some very positive and encouraging outcomes. The characteristics of these mesoporous materials needed for maximum loading of the drug and then the subsequent release of drug from the host can give the idea about the suitability of these materials as drug carriers. The manuscript describes various morphological properties of mesoporous materials which can favour the maximum drug loading in the mesopores. The subsequent release of the drug trapped from the mesopores can be tailored to a specific site release (targeted drug delivery), release at a slow rate (sustained drug delivery) or fast or immediate release so that it can show maximum biological activity. Most of the studies have shown great potential of these mesoporous materials as a carrier to carry sufficient amount of the drug and release it in a desired manner. The review presents the current status of the applications of mesoporous materials as host for drug molecules.
“…This allows for exact checks on the release of cargo using a stimulus, whether internal and pathological characteristics are addressed or whether the physician is external. The regulation provided by the MSNs-responsive mechanism prevents the early release of the therapeutic substance, which could be important in preventing systemic toxicity (Cauda et al 2020;Zhou et al 2018;Vallet-Regí et al 2018). By modifying the physicochemical parameters of the chosen mesoporous materials, the nature of the drug's interactions can be altered.…”
Section: Applicability Of Mesoporous Materials For Sustained or Controlled Drug Delivery Systemsmentioning
Effective treatment of patients suffering from fatal diseases such as cancer, AIDS, tuberculosis, etc., has always been a challenge, and new approaches are continuously explored so as to prevent or reduce the toxic side effects of such drugs. The exploration of silica-based mesoporous nanoparticles as a host for better therapeutic action of drugs has provided some very positive and encouraging outcomes. The characteristics of these mesoporous materials needed for maximum loading of the drug and then the subsequent release of drug from the host can give the idea about the suitability of these materials as drug carriers. The manuscript describes various morphological properties of mesoporous materials which can favour the maximum drug loading in the mesopores. The subsequent release of the drug trapped from the mesopores can be tailored to a specific site release (targeted drug delivery), release at a slow rate (sustained drug delivery) or fast or immediate release so that it can show maximum biological activity. Most of the studies have shown great potential of these mesoporous materials as a carrier to carry sufficient amount of the drug and release it in a desired manner. The review presents the current status of the applications of mesoporous materials as host for drug molecules.
“…Lately, scientists are making great efforts to improve the delivery and effectiveness of drugs using different approaches such as loading to polylactic acid microspheres, lipid nanoparticles or modifying them by glycosylation [ 36 , 37 , 38 , 39 , 40 ]. One of the possibilities for improving delivery and targeting is the use of mesoporous silica nanoparticles such as nontoxic SBA-15 (Santa Barbara Amorphous 15) [ 41 ]. Recently, it was reported that SBA-15 loaded with cisplatin, organotin (IV) compounds or titanocene dichloride and its derivatives can reduce tumor cell growth [ 42 , 43 , 44 , 45 , 46 ].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the apo inducing property of XN is transformed into a preference of autophagic cell death bling tumor repopulation in response to apoptotic-induced cell proliferation, a m nism that is tightly connected with therapy failure in advanced forms of cancer [47 Lately, scientists are making great efforts to improve the delivery and effectiveness of drugs using different approaches such as loading to polylactic acid microspheres, lipid nanoparticles or modifying them by glycosylation [36][37][38][39][40]. One of the possibilities for improving delivery and targeting is the use of mesoporous silica nanoparticles such as nontoxic SBA-15 (Santa Barbara Amorphous 15) [41]. Recently, it was reported that SBA-15 loaded with cisplatin, organotin (IV) compounds or titanocene dichloride and its derivatives can reduce tumor cell growth [42][43][44][45][46].…”
Xanthohumol (XN) and isoxanthohumol (IXN), prenylated flavonoids from Humulus lupulus, have been shown to possess antitumor/cancerprotective, antioxidant, antiinflammatory, and antiangiogenic properties. In this study, mesoporous silica (SBA-15) was loaded with different amounts of xanthohumol and isoxanthohumol and characterized by standard analytical methods. The anticancer potential of XN and IXN loaded into SBA-15 has been evaluated against malignant mouse melanoma B16F10 cells. When these cells were treated with SBA-15 containing xanthohumol, an increase of the activity correlated with a higher immobilization rate of XN was observed. Considering the amount of XN loaded into SBA-15 (calculated from TGA), an improved antitumor potential of XN was observed (IC50 = 10.8 ± 0.4 and 11.8 ± 0.5 µM for SBA-15|XN2 and SBA-15|XN3, respectively; vs. IC50 = 18.5 ± 1.5 µM for free XN). The main mechanism against tumor cells of immobilized XN includes inhibition of proliferation and autophagic cell death. The MC50 values for SBA-15 loaded with isoxanthohumol were over 300 µg/mL in all cases investigated.
“…The crucial step in tracing bacteria is the selection of bacteriatracing agents, which include antibodies, [5] sugars, [6] antimicrobial peptides, [7] 67 Ga-citrate, radiolabeled leukocytes, and 18 F-fluorodeoxyglucose (FDG). [8][9][10] Ubiquicidin (UBI) [29][30][31][32][33][34][35][36][37][38][39][40][41] , which contains six positive amino acids, is a synthetic cationic bactericidal peptide fragment and can preferentially bind to the anionic bacterial cell membranes accumulated at the site of infection. [11] Based on this mechanism, UBI 29-41 combined with 99m Tc, 68 Ga, or near-infrared fluorescent dye has been widely investigated for use in the diagnosis of infection or as a target to trace bacteria.…”
Section: Introductionmentioning
confidence: 99%
“…[11] Based on this mechanism, UBI 29-41 combined with 99m Tc, 68 Ga, or near-infrared fluorescent dye has been widely investigated for use in the diagnosis of infection or as a target to trace bacteria. [12][13][14] Recently, 99m Tc-UBI [29][30][31][32][33][34][35][36][37][38][39][40][41] has been investigated as an adjunct to bone scans to differentiate between infected and aseptic loosening of prostheses before revision surgery. [15][16][17][18] Traditional antibiotics still have many shortcomings in the treatment of infection-related diseases.…”
Bacterial infections are a major complication in human healthcare. Bacteria tracing and targeted delivery of antibiotics to bacterial infection sites are being developed to reduce the high mortality caused by pathogenic bacterial infections. Owing to the challenges in accurate diagnosis of infection, particularly the identification of biomaterial‐related bacteria, the use of bacteria‐targeting nanomaterials has become increasingly important. Herein, magnetic core–shell mesoporous silica nanoparticles (MSNs) are fabricated for targeted drug delivery; the shell is modified with ubiquicidin (UBI)29‐41 for bacteria targeting, and vancomycin is loaded into the channels of the MSNs. The results demonstrate that magnetic core–shell MSNs display the desired functions of drug loading, bacteria targeting, detectability in magnetic resonance imaging, antibacterial action, and good in vitro biocompatibility. Magnetic core–shell MSNs have potential applications in the treatment of diseases caused by infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.